Followers | 507 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, December 17, 2014 10:00:05 AM
bullish
$NVGN recent news/filings
## source: finance.yahoo.com
Tue, 16 Dec 2014 15:00:00 GMT ~ Novogen Announces Breakthrough Discovery in the Treatment of Melanoma
[PR Newswire] - NASDAQ:NVGN), Australian/US biotechnology company, today announces that it has confirmed that its lead candidate product, TRXE-009, originally developed for the treatment of brain cancers, has been shown in pre-clinical studies also to be highly active against melanoma. The Company believes this is an important breakthrough discovery for two reasons. The first is that it confirms that TRXE-009 is an important new potential treatment for melanoma, including for the treatment of secondary brain cancers due to melanoma, for which there currently are no effective therapies. The second is that it offers evidence for the first time of an hypothesized link between brain cancer and melanoma.
read full: http://finance.yahoo.com/news/novogen-announces-breakthrough-discovery-treatment-150000979.html
*********************************************************
Tue, 16 Dec 2014 14:36:33 GMT ~ Novogen Shares Skyrocket 120% Following Drug News
read full: http://finance.yahoo.com/news/novogen-shares-skyrocket-120-following-143633694.html
*********************************************************
Tue, 16 Dec 2014 11:36:00 GMT ~ 6:36 am Novogen announced that it has confirmed that its lead candidate product, TRXE-009, has been shown in pre-clinical studies also to be highly active against melanoma
read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#nvgn
*********************************************************
Mon, 15 Dec 2014 14:00:00 GMT ~ Novogen Provides Update On Progress Of Cantrixil Into The Clinic
[PR Newswire] - SYDNEY, Dec. 15, 2014 /PRNewswire/ -- Novogen Ltd (ASX: NRT, NASDAQ: NVGN) is an Australian/US biotechnology company that has developed a first-in-class experimental chemotherapeutic known as Cantrixil, which is due to enter a first-in-man clinical study in 2015. The Company has posted a video on its website reporting on the status of this clinical trial program. The peritoneal and pleural cavities are involved in a large proportion of cancers, and yet the vast majority of chemotherapies continue to be administered in a way that delivers chemotherapies to the cancer via the bloodstream. Delivering the drug directly into the cavity where the cancer is spreading ensures cancer cells are exposed to levels of drug some hundreds of times greater than via the blood.
read full: http://finance.yahoo.com/news/novogen-provides-progress-cantrixil-clinic-140000267.html
*********************************************************
Mon, 29 Sep 2014 12:00:00 GMT ~ Graham Kelly PhD, CEO & Chairman attended the Rodman & Renshaw 16th Annual Global Investment Conference
[GlobeNewswire] - SYDNEY -- Novogen Ltd. (ASX: NRT, NASDAQ: NVGN)
read full: http://finance.yahoo.com/news/graham-kelly-phd-ceo-chairman-120000568.html
*********************************************************
$NVGN charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$NVGN company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NVGN/company-info
Ticker: $NVGN
OTC Market Place: Not Available
CIK code: 0001075880
Company name: Novogen Ltd.
Company website: http://www.novogen.com
Incorporated In: Australia
$NVGN share structure
## source: otcmarkets.com
Market Value: $434,303 a/o Dec 16, 2014
Shares Outstanding: 2,018,137 a/o Jan 03, 2011
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$NVGN extra dd links
Company name: Novogen Ltd.
Company website: http://www.novogen.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NVGN+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NVGN+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NVGN+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/news - http://finance.yahoo.com/q/h?s=NVGN+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NVGN/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NVGN+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NVGN
DTCC (dtcc.com): http://search2.dtcc.com/?q=Novogen+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Novogen+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Novogen+Ltd.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.novogen.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.novogen.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.novogen.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NVGN
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001075880&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NVGN&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NVGN
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NVGN+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NVGN+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NVGN
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NVGN
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NVGN+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NVGN/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NVGN+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NVGN.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NVGN
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NVGN
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NVGN
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NVGN:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NVGN
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NVGN
$NVGN DD Notes ~ http://www.ddnotesmaker.com/NVGN
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM